Infosys foundation signs Rs 5 crore MoU with IISc for Infectious Diseases Research

Published On 2017-09-26 08:31 GMT   |   Update On 2017-09-26 08:31 GMT

BENGALURU: Infosys Foundation, the philanthropic arm of Infosys, has signed a Rs five crore MoU with Indian Institute of Science, Bangalore, to enhance infrastructure and broaden research activities at the centre for Infectious Diseases Research (CIDR)."With this MoU, Infosys Foundation aims to set milestones in the area of research of infectious diseases.We will focus on...

Login or Register to read the full article

BENGALURU: Infosys Foundation, the philanthropic arm of Infosys, has signed a Rs five crore MoU with Indian Institute of Science, Bangalore, to enhance infrastructure and broaden research activities at the centre for Infectious Diseases Research (CIDR).


"With this MoU, Infosys Foundation aims to set milestones in the area of research of infectious diseases.


We will focus on motivating researchers to perform cutting-edge research, as well as train them to raise awareness about infectious diseases," Infosys Foundation Chairperson Sudha Murthy said in a statement here.


Rs 5 crore grant will be used towards research, training and create awareness, about infectious diseases, benefit 25 faculty members and 250 students at IISc, Murthy said.


IISc is a public university for research and higher education in all science and engineering disciplines.


This association will facilitate an interdisciplinary approach, with a focus on research about infectious diseases, leading to the development of new drug targets, drug delivery systems and novel diagnostic tools, she said.

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News